Exelixis Inc. buy Guggenheim
Start price
12.02.25
/
50%
€31.91
Target price
12.02.26
€40.45
Performance (%)
16.11%
End price
13.02.26
€37.05
Summary
This prediction ended on 13.02.26 with a price of €37.05. The prediction had a final performance of 16.11%. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Exelixis Inc. | -5.280% | -5.280% | 34.151% |
| iShares Core DAX® | 0.437% | 5.640% | 7.806% |
| iShares Nasdaq 100 | 1.057% | 0.282% | 27.239% |
| iShares Nikkei 225® | 1.769% | 0.406% | 49.266% |
| iShares S&P 500 | 0.368% | 1.920% | 22.336% |
Comments by Guggenheim for this prediction
In the thread Exelixis Inc. diskutieren
Exelixis, Inc. (NASDAQ: EXEL) had its "buy" rating re-affirmed by analysts at Guggenheim. They now have a $42.00 price target on the stock.
Ratings data for EXEL provided by MarketBeat
In the thread Trading Exelixis Inc.
Die von Guggenheim gewählte maximale Laufzeit wurde überschritten